Taylor Miller, MD

Residency: University of Maryland
Medical school: Icahn School of Medicine at Mount Sinai

As much of the U.S. experiences a resurgence of COVID-19 cases heading into the height of summer, research continues at a brisk pace. Can dexamethasone - a relatively inexpensive, commonly prescribed
The Adaptive COVID-19 Treatment Trial (ACTT), while controversial, is the first major trial to suggest benefit from remdesivir for hospitalized COVID-19 patients. Unfortunately, study results don't sh
In the quest to conquer sepsis, a new randomized controlled trial has tested hydrocortisone, vitamin C, and thiamine as a treatment.
The first RCT studying the use of dexamethasone in ARDS shows promise for the emergency medicine setting.
CHAT NOW
CHAT OFFLINE